Akebia Therapeutics Inc. (NASDAQ:AKBA) Archives - BioPharmaJournal

Home Tags Akebia Therapeutics Inc. (NASDAQ:AKBA)

Akebia Therapeutics Inc. (NASDAQ: AKBA) Amends and Restates Terms of Agreement...

Kate Hudson - March 4, 2022 0

Akebia Therapeutics Inc. (NASDAQ: AKBA) Will Present Vadadustat Safety And Efficacy...

Matt Wade - October 26, 2021 0

Akebia Therapeutics Inc. (NASDAQ:AKBA) Publishes INNO2VATE Program In The Nephrology Dialysis...

Matt Wade - December 10, 2020 0

Akebia Therapeutics Inc. (NASDAQ:AKBA) Announces Q3 Results And Updates About Pre-NDA...

Ward Sport - November 11, 2020 0

Akebia Therapeutics Inc. (NASDAQ:AKBA) Presents Positive INNO¬2VATE Phase 3 Clinical Vadadustat...

Ward Sport - October 27, 2020 0

Results from PRO2TECT Global Phase 3 Program of Vadadustat Were Top-Line;...

Gavins Felicity - September 9, 2020 0

The Commercial Launch of VAFSEO™ (vadadustat tablets) by Akebia Therapeutics Inc....

Ward Sport - September 2, 2020 0

Recent Post

What to expect from GOOGL Earnings this week

Gavins Felicity - January 29, 2023 0

Alphabet Inc Class A (NASDAQ: GOOGL) will be reporting earnings and holding a conference call at 4:30 PM ET on Thursday.

Lucid Motors (LCID) could be a falling knife for retail traders

January 27, 2023

BuzzFeed Inc (NASDAQ:BZFD) surge could be just getting started

January 26, 2023

Invesco QQQ Trust Series 1 (NASDAQ:QQQ) looks to bounce back as...

January 25, 2023

Esports Entertainment Group Inc (GMBL) could keep surging as online iGaming...

January 24, 2023